96 related articles for article (PubMed ID: 15237461)
21. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M
Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
[No Abstract] [Full Text] [Related]
23. How can we determine the role of radiotherapy in the treatment of localized aggressive non-Hodgkin's lymphoma?
Gemici C; Salepci T
J Clin Oncol; 2007 Jul; 25(19):2857; author reply 2857-8. PubMed ID: 17602093
[No Abstract] [Full Text] [Related]
24. Use of rituximab in diffuse large B-cell lymphoma in the salvage setting.
Gisselbrecht C
Br J Haematol; 2008 Dec; 143(5):607-21. PubMed ID: 18950460
[TBL] [Abstract][Full Text] [Related]
25. Current status of the treatment of HIV-associated lymphoma.
Kaplan LD
Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156
[No Abstract] [Full Text] [Related]
26. Treatment of localized lymphoma.
Adli M; Sevinc A; Kalender ME
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948268
[No Abstract] [Full Text] [Related]
27. Treatment of localized lymphoma.
Hoecht S; Hinkelbein W
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948267
[No Abstract] [Full Text] [Related]
28. [A pregnant woman with autoimmune thyroiditis and recurrent goiter].
Santoe MF; Van Houten AA; Muller AF; Berghout A
Ned Tijdschr Geneeskd; 2004 Jul; 148(29):1455-9. PubMed ID: 15326651
[TBL] [Abstract][Full Text] [Related]
29. Syngeneic transplant in mantle cell lymphoma: a rare event and review of the literature.
Engman CA; Hill JM; Meehan KR
Clin Adv Hematol Oncol; 2009 May; 7(5):321-3. PubMed ID: 19521320
[No Abstract] [Full Text] [Related]
30. Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy.
Siracusano L; Balzarotti M; Magagnoli M; Castagna L; Rahal D; Santoro A
Am J Hematol; 2005 Apr; 78(4):312-3. PubMed ID: 15795908
[TBL] [Abstract][Full Text] [Related]
31. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Basaran G; Basaran M; Onat H
J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
[No Abstract] [Full Text] [Related]
32. Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study.
Lefrère F; Delmer A; Levy V; Delarue R; Varet B; Hermine O
Haematologica; 2004 Oct; 89(10):1275-6. PubMed ID: 15477221
[TBL] [Abstract][Full Text] [Related]
33. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
Mazzarotto R; Boso C; Vianello F; Aversa MS; Chiarion-Sileni V; Trentin L; Zambello R; Muzzio PC; Fiore D; Sotti G
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):823-9. PubMed ID: 17379431
[TBL] [Abstract][Full Text] [Related]
34. [Radiotherapy indications in non-Hodgkin lymphoma].
Quero L; Hennequin C; Brice P
Cancer Radiother; 2009 Oct; 13(6-7):471-8. PubMed ID: 19695926
[TBL] [Abstract][Full Text] [Related]
35. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
36. [Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
Okada S
Rinsho Ketsueki; 2008 Oct; 49(10):1490-8. PubMed ID: 18833933
[No Abstract] [Full Text] [Related]
37. Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab era.
Friedberg JW
Clin Cancer Res; 2004 Aug; 10(16):5297-8. PubMed ID: 15328164
[No Abstract] [Full Text] [Related]
38. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
[TBL] [Abstract][Full Text] [Related]
39. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Dreyling M; Hiddemann W
Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
[TBL] [Abstract][Full Text] [Related]
40. Overview of Southwest Oncology Group clinical trials in non-Hodgkin lymphoma.
Fisher RI
Clin Adv Hematol Oncol; 2005 Jul; 3(7):544-6. PubMed ID: 16167035
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
